ONCOGENES - A REVIEW OF THEIR CLINICAL-APPLICATION

被引:7
作者
DEMCZUK, S
机构
[1] KAROLINSKA INST, NOVUM, CTR BIOTECHNOL, HUDDINGE, SWEDEN
[2] KAROLINSKA INST, KAROLINSKA HOSP, INST EXPTL ALCOHOL & NARCOT RES, STOCKHOLM, SWEDEN
关键词
D O I
10.1016/1040-8428(91)90021-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
One objective of this review is to sort through and collate the recent data that suggest that human cellular oncogenes, which have been implicated as the etiologic agents in both animal and human malignancies, have also the potential to be employed as clinical tools in the struggle against cancer. For nearly 10 years, reports have been suggesting that advantage can be taken of cellular oncogenes as to their use as diagnostic and prognostic indicators of cancer and eventually as therapeutic cancer agents. It is also the purpose of this review to give an objective evaluation of these predictions. Moreover, this review will try to highlight some of the significant advances in this most rapidly evolving field of biology. Although the enormity of what has been learned about cellular oncogenes is nothing less than impressive, it is the view here that the routine implementation of oncogenes into the clinical setting will not become evident as early as the many predictions had purported.
引用
收藏
页码:209 / 239
页数:31
相关论文
共 495 条
[91]   THE BCL-2 CANDIDATE PROTO-ONCOGENE PRODUCT IS A 24-KILODALTON INTEGRAL-MEMBRANE PROTEIN HIGHLY EXPRESSED IN LYMPHOID-CELL LINES AND LYMPHOMAS CARRYING THE T(14,18) TRANSLOCATION [J].
CHENLEVY, Z ;
NOURSE, J ;
CLEARY, ML .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (02) :701-710
[92]   CLONING AND STRUCTURAL-ANALYSIS OF CDNAS FOR BCL-2 AND A HYBRID BCL-2/IMMUNOGLOBULIN TRANSCRIPT RESULTING FROM THE T(14-18) TRANSLOCATION [J].
CLEARY, ML ;
SMITH, SD ;
SKLAR, J .
CELL, 1986, 47 (01) :19-28
[93]  
CLEMENTI E, 1990, ONCOGENE, V5, P1059
[94]   ONCOGENES IN HEMATOLOGIC NEOPLASIA [J].
CLINE, MJ .
INTERNATIONAL JOURNAL OF CELL CLONING, 1989, 7 (04) :213-222
[95]   PROTOONCOGENE ABNORMALITIES IN HUMAN-BREAST CANCER - CORRELATIONS WITH ANATOMIC FEATURES AND CLINICAL COURSE OF DISEASE [J].
CLINE, MJ ;
BATTIFORA, H ;
YOKOTA, J .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (07) :999-1006
[96]   ONCOGENES - IMPLICATIONS FOR THE DIAGNOSIS AND TREATMENT OF CANCER [J].
CLINE, MJ ;
SLAMON, DJ ;
LIPSICK, JS .
ANNALS OF INTERNAL MEDICINE, 1984, 101 (02) :223-233
[97]  
COOKE M P, 1989, New Biologist, V1, P66
[98]  
COPELAND NG, 1990, ADV CANCER RES, P141
[99]   ONCOGENE ACTIVATION IN HUMAN BENIGN-TUMORS OF THE SKIN (KERATOACANTHOMAS) - IS HRAS INVOLVED IN DIFFERENTIATION AS WELL AS PROLIFERATION [J].
COROMINAS, M ;
KAMINO, H ;
LEON, J ;
PELLICER, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (16) :6372-6376
[100]   PERMANENT EXPRESSION OF P53 IN FR-3T3 RAT-CELLS BY CELL CYCLE-DEPENDENT ASSOCIATION WITH LARGE-T-ANTIGEN IN SIMIAN VIRUS-40 TRANSFORMANTS [J].
COULIER, F ;
IMBERT, J ;
ALBERT, J ;
JEUNET, E ;
LAWRENCE, JJ ;
CRAWFORD, L ;
BIRG, F .
EMBO JOURNAL, 1985, 4 (13A) :3413-3418